Aphria Inc. (“Aphria” or the “Company“) (TSX: APH and US OTC: APHQF) today provided an update related to its previously announced plan to divest of its equity investments in Liberty Health Sciences, Inc. (“Liberty“). Aphria is amending its put and call agreement, effective July 26, 2018, pertaining to its sale of shares in Liberty and intends […]
